MiRXES’ patented reverse transcription (RT)-quantitative polymerase chain reaction (qPCR) technology platform enables sensitive, specific, and robust detection of microRNAs and other non-coding RNAs in biofluids and tissue samples.
Rankings by 
National Ranking
21st
in SingaporeRegional Ranking
65th
in South East AsiaGlobal Ranking
1295th
worldwide